|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1994)) |
IUPAC Name ![]() |
| (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 3879 | fluvoxamine |
Synonyms ![]() |
| Luvox® |
| U-23000 |
Database Links ![]() |
|
| CAS Registry No. | 54739-18-3 |
| ChEBI | CHEBI:5138 |
| ChEMBL Ligand | CHEMBL814 |
| DrugBank Ligand | DB00176 |
| PubChem CID | 5324346 |
| RCSB PDB Ligand | FVX |
| Search Google for chemical match using the InChIKey | CJOFXWAVKWHTFT-XSFVSMFZSA-N |
| Search Google for chemicals with the same backbone | CJOFXWAVKWHTFT |
| Search PubMed clinical trials | fluvoxamine |
| Search PubMed titles | fluvoxamine |
| Search PubMed titles/abstracts | fluvoxamine |
| Wikipedia | Fluvoxamine |
| Comments |
| Fluvoxamine is an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) drug group. Marketed formulations may contain fluvoxamine maleate (PubChem CID 9560989). |